Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
164.49
+2.16 (1.33%)
At close: Mar 9, 2026, 4:00 PM EDT
164.63
+0.14 (0.09%)
After-hours: Mar 9, 2026, 7:19 PM EDT
Axsome Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 322.93 | 315.35 | 386.19 | 200.84 | 86.47 | Upgrade
|
| Cash & Short-Term Investments | 322.93 | 315.35 | 386.19 | 200.84 | 86.47 | Upgrade
|
| Cash Growth | 2.40% | -18.34% | 92.29% | 132.26% | -52.97% | Upgrade
|
| Receivables | 224.46 | 142 | 94.82 | 37.7 | - | Upgrade
|
| Inventory | 27.94 | 15.73 | 15.14 | 4.32 | - | Upgrade
|
| Prepaid Expenses | 13.65 | 11.98 | 8.12 | 2.78 | 0.05 | Upgrade
|
| Total Current Assets | 588.99 | 485.06 | 504.26 | 245.64 | 86.52 | Upgrade
|
| Property, Plant & Equipment | 21.42 | 5.97 | 7.62 | 1.14 | 0.94 | Upgrade
|
| Goodwill | 12.04 | 12.04 | 12.04 | 10.31 | - | Upgrade
|
| Other Intangible Assets | 40.52 | 46.89 | 53.29 | 59.66 | - | Upgrade
|
| Other Long-Term Assets | 26.84 | 18.53 | 11.03 | 14.72 | 0.32 | Upgrade
|
| Total Assets | 689.81 | 568.5 | 588.24 | 331.48 | 87.79 | Upgrade
|
| Accounts Payable | 65.54 | 72 | 40.68 | 38.61 | 13.15 | Upgrade
|
| Accrued Expenses | 230.21 | 145.61 | 90.5 | 51.63 | 9.3 | Upgrade
|
| Short-Term Debt | 70 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 2.98 | 3.26 | 1.27 | 0.43 | 0.62 | Upgrade
|
| Current Income Taxes Payable | 0.1 | 0.96 | - | - | - | Upgrade
|
| Other Current Liabilities | 10.01 | 8.29 | 6.41 | 5.9 | - | Upgrade
|
| Total Current Liabilities | 378.84 | 230.1 | 138.85 | 96.56 | 23.07 | Upgrade
|
| Long-Term Debt | 117.75 | 180.71 | 178.07 | 94.26 | 49.09 | Upgrade
|
| Long-Term Leases | 27.39 | 8.99 | 7.04 | - | - | Upgrade
|
| Other Long-Term Liabilities | 77.54 | 91.68 | 73.3 | 31.1 | - | Upgrade
|
| Total Liabilities | 601.51 | 511.48 | 397.26 | 221.92 | 72.15 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,394 | 1,180 | 1,027 | 705.89 | 424.83 | Upgrade
|
| Retained Earnings | -1,306 | -1,123 | -835.57 | -596.33 | -409.2 | Upgrade
|
| Shareholders' Equity | 88.3 | 57.02 | 190.98 | 109.56 | 15.63 | Upgrade
|
| Total Liabilities & Equity | 689.81 | 568.5 | 588.24 | 331.48 | 87.79 | Upgrade
|
| Total Debt | 218.11 | 192.96 | 186.37 | 94.68 | 49.71 | Upgrade
|
| Net Cash (Debt) | 104.82 | 122.4 | 199.82 | 106.16 | 36.76 | Upgrade
|
| Net Cash Growth | -14.36% | -38.75% | 88.23% | 188.77% | -72.51% | Upgrade
|
| Net Cash Per Share | 2.11 | 2.55 | 4.40 | 2.61 | 0.98 | Upgrade
|
| Filing Date Shares Outstanding | 51.15 | 48.77 | 47.37 | 43.52 | 38.48 | Upgrade
|
| Total Common Shares Outstanding | 50.88 | 48.67 | 47.35 | 43.5 | 37.82 | Upgrade
|
| Working Capital | 210.15 | 254.96 | 365.41 | 149.08 | 63.45 | Upgrade
|
| Book Value Per Share | 1.74 | 1.17 | 4.03 | 2.52 | 0.41 | Upgrade
|
| Tangible Book Value | 35.73 | -1.92 | 125.65 | 39.59 | 15.63 | Upgrade
|
| Tangible Book Value Per Share | 0.70 | -0.04 | 2.65 | 0.91 | 0.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.